Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

類似資料

• Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials
  著者:: Panaccione, Remo, 等
  出版事項: (2018)
• Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial
  著者:: Reinisch, Walter, 等
  出版事項: (2017)
• Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
  著者:: Panaccione, Remo, 等
  出版事項: (2020)
• Efficacy and Safety of Adalimumab in Crohn's Disease
  著者:: Lichtenstein, Gary R., 等
  出版事項: (2008)
• Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
  著者:: Panaccione, R, 等
  出版事項: (2013)